1
|
Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement.
|
Ann Hematol
|
2011
|
1.02
|
2
|
Prognostic value of metabolic tumor volume on PET / CT in primary gastrointestinal diffuse large B cell lymphoma.
|
Cancer Sci
|
2012
|
1.00
|
3
|
Clinical value of metabolic tumor volume by PET/CT in extranodal natural killer/T cell lymphoma.
|
Leuk Res
|
2012
|
0.80
|
4
|
Prognostic value of Waldeyer's ring involvement of diffuse large B-cell lymphoma treated with R-CHOP.
|
Int J Hematol
|
2013
|
0.77
|
5
|
Analysis of hyperpigmentation and hypopigmentation after Er:YAG laser skin resurfacing.
|
Lasers Surg Med
|
2005
|
0.76
|
6
|
Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma.
|
Eur J Haematol
|
2014
|
0.75
|
7
|
Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairment.
|
Ann Hematol
|
2012
|
0.75
|